作者: Katherine E. Poruk , Matthew A. Firpo , Sean J. Mulvihill
DOI: 10.1016/J.YASU.2014.05.004
关键词:
摘要: Even with improved cancer care generally, the incidence and death rate is increasing for pancreatic cancer. Concern exists that a further increase in deaths caused by will be seen as other causes of death, such heart disease cancers, decline. Critical exploration screening high-risk patients tool to reduce from should considered. Technological advances understanding biology provides an opportunity identify test panel early detection biomarkers easily, accurately, inexpensively measured blood, urine, stool, or saliva samples. These may have additional usefulness staging, stratification treatment, establishing prognosis, assessing response therapy this disease. Screening prove one several strategies improve outcomes has otherwise been difficult defeat.